Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
101BHG-D01 Nasal Spray in Seasonal Allergic Rhinitis
CTR20222288Phase 2Completed
- Sponsor
- Beijing Shuobai Pharmaceutical Technology
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 101BHG-D01 in seasonal allergic rhinitis (SAR), sponsored by Beijing Shuobai Pharmaceutical Technology. Started Sep 2022; status: completed.
02
Drugs
101BHG-D01
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on CTR20222288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222288.